维普中文期刊产品整合服务
23篇 您的检索式:作者名="Su DG"
    题名 作者 年代 出处 被引量
1Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii:Philos Trans R Soc Lond B 显示文摘Sibley LD Mordue DG Su C 2002Biol Sci2002,357,1417:1
2Concurrent cetuximab, cisplatin and concomitant boost radiotherapy for locoregioaally advanced, squamous cell head and neck cancer: a pilot phase Ⅱ study of a new combined-modality paradigm显示文摘Pfister DG Su YB Kraus DH 2006J Clin 0ncol2006,24,7:1
3Proteome analysis of human stomach tissue:separation of soluble proteins by two-dimensional polyacrylamide gel electrophoresis and identification by mass spectrometry显示文摘Ha GH Lee SU Kang DG 2002Electrophoresis2002,23,15:1
4Application of in vitro neurotoxicity testing for regulato-ry purposes:SymposiumⅢsummary and research needs显示文摘Bal-Price AK Suol C Weiss DG van Vliet E Westerink RH Costa LG 2008Neurotoxicology2008,29,3:1
5Concurrent cetuximab, cisplatin and concomitant boost radiotherapy for localregionally advanced sqummous cell of the head and neck carcer: a pilot phase II study of a new combined-modality paradigm 显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
6Lapatinib (tykerb, GW572016) reverses muhidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2 显示文摘Dai CL Tiwari AK Wu CP Su XD Wang SR Liu DG 200868 (19): 7905- 79142008,68,19:1
7Proteome analysis of human stomach tissue: separation of soluble proteins by two-dimensional polyacrylamide gel electrophoresis and identification by mass spectrometry显示文摘 Lee SU Kang DG 2002Electrophoresis2002,23,15:1
8Concurrent cetuximab,cisplatin,and concomitant boost radiotherapy for locoregionally advanced,squamous cell head and neck cancer:a pilot phase II study of a new combined-modality paradigm显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
9Evaluation of cortisol levels in gingival crevicular fluid and saliva in anxious and non-anxious patients with chronic periodontitis显示文摘Nayak SU Nayak DG Uppoor AS 2013Dent Res J(Isfahan)2013,10,4:1
10Concurrent cetuximab,cisplatin,and concomitant boost radiotherapy for locoregionally advanced,squamous cell head and neck cancer:a pilot phase II study of a new combined-modality paradigm显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,:1
11Lapatinib (tykerb, GW572016) reverses muhidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette suhfamily B member 1 and G member 2 显示文摘Dai CL Tiwari AK Wu CP Su XD Wang SR Liu DG 2008Cancer Res2008,68,19:1
12Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer:, a pilot phase Ⅱ study of a new combined-modality paradigm 显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
13Concurrent cetuximab,cisplatin,and concomitant boost radiotherapy for locoregionally advanced,squamous cell head and neck cancer:a pilot phase II study of a new combined-modality paradigm显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
14Genetic approaches to studying virulence and pathogenesis in Toxoplasma gorrdii显示文摘SIBLEY LD MORDUE DG SU C 2002Philos Trans R Soc Lond B Biol Sci2002,357,1417:1
15Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase lI study of a new combined-modality paradigm 显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
16Concurrent cetuximab, cis- platin, and concomitant boost radiotherapy for locoregionally ad- vanced, squamous cell head and neck cancer: a pilot phase lI study of a new combined - modality paradigm 显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
17Concurrent cetuximab,cisplatin,and concomitant boost radiotherapy for locoregionally advanced,squamous cell head and neck cancer:a pilot phase Ⅱ study of a new combined-modality paradigm显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,:1
18Attenuating burn wound inflammatory signalingreduces systemic inflammation and acute lung injury显示文摘Ipakt chi K Ma t t a r A N i ede rbi chl e r AD Hoe s e l LM Vollmannshauser S Hemmila MR Su GL Remick DG WangSC Arbabi S 2006JImmunol2006,177,11:1
19In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles显示文摘Su X Frieke J Kavanagh DG 2011Mol Pharm2011,8,3:1
20Concurrent cetuximab,cisplatin,and concomitant boost radiotherapy for locoregionally advanced,squamous cell head and neck cancer:a pilot phase Ⅱ study of a new combined-modality paradigm显示文摘Pfister DG Su YB Kraus DH 2006J Clin Oncol2006,24,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费